Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The P2X purinergic receptor family comprises trimeric ligand-gated ion channels activated exclusively by extracellular ATP, mediating fast excitatory responses across many tissues. Their broad distribution underlies their involvement in neurotransmission, nociception/pain pathways—including neuropathic/inflammatory conditions—immune responses via inflammasome activation (notably through subtype-specific effects like those mediated by P2RX7), vascular tone regulation, platelet function modulation—and they represent promising therapeutic targets for several major disease areas due to their unique pharmacology and pathophysiological roles.
Antagonism of P2X receptor subtypes, Allosteric modulation
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on P2X Purinergic Receptor (P2XR).